Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Cure8 research brief
Why This Matters
Parents and clinicians often worry about liver disease when children are diagnosed with Crohn's. This study suggests advanced liver fibrosis is uncommon at diagnosis, but elastography and fibrotic biomarkers can be affected by intestinal inflammation.
Who Should Pay Attention
Parents and caregivers of newly diagnosed pediatric Crohn's patients; pediatric gastroenterologists; researchers interested in IBD-related liver involvement and biomarkers.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study reports a noninvasive liver evaluation performed at diagnosis in 50 children with newly diagnosed Crohn's disease versus 23 healthy controls.
Researchers measured liver stiffness by elastography, calculated noninvasive fibrosis scores, and tested serum levels of two fibrotic biomarkers (FGF-19 and CTGF) alongside routine liver tests and fecal calprotectin.
No child met criteria for advanced hepatic fibrosis; only one patient had elastography consistent with moderate (F2) fibrosis, and overall liver stiffness did not differ between Crohn's and control groups.
Liver stiffness showed a positive correlation with fecal calprotectin, linking higher stiffness readings to intestinal inflammation rather than established liver fibrosis. Children with Crohn's had lower serum FGF-19 and higher CTGF than controls.
The authors suggest these altered biomarker levels may reflect intestinal inflammation or a gut fibrotic response, not necessarily liver fibrosis. The study emphasizes careful interpretation of elastography and biomarkers in newly diagnosed pediatric CD because intestinal disease activity can influence results.
Keep In Mind
This summary is grounded in the article abstract. The sample size is limited and represents findings at diagnosis; longitudinal studies are needed to assess later liver outcomes. Altered FGF-19 and CTGF may reflect gut processes rather than liver fibrosis.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationAdvances in clinical and experimental medicine : official organ Wroclaw Medical University
AuthorsAleksandra Katarzyna Medyńska-Przęczek, Anna Stochel-Gaudyn, Przemysław Jan Tomasik +4 more
InstitutionDoctoral School of Medical and Health Sciences, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedOct 20, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
C-Reactive Protein-to-Albumin Ratio in Pediatric Inflammatory Bowel Disease: Associations with Disease Activity and Comparison with C-Reactive Protein Alone
This paper evaluates CAR, a simple blood‑based biomarker, in children with IBD and finds it reflects disease severity and changes over time in pediatric Crohn’s disease. That matters because reliable, easy-to-measure...
Leucine-rich alpha-2 glycoprotein reflects transmural inflammation assessed by through-the-scope endoscopic ultrasonography: A prospective study in small-bowel Crohn’s disease
A blood biomarker that reflects transmural inflammation could help monitor small-bowel Crohn’s disease noninvasively and might predict risk of rehospitalization.
Crohn᾿s Disease and Ulcerative Colitis: The Role of Endoscopic, Hemogram-derived, Nutritional, and Hepatic Scores
Non-invasive biomarkers that reflect mucosal inflammation and systemic disease activity could help reduce reliance on frequent endoscopy and guide monitoring for people with Crohn’s disease or ulcerative colitis.